Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Peter Diamandis - aVenture Research

Peter Diamandis

AddedMar 31, 2024

UpdatedOct 17, 2026

Peter Diamandis

Peter Diamandis

Co-Founder, Singularity University

Peter Diamandis's Career

Singularity University

Peter Diamandis's Co-Investors

Serena WilliamsCo-invested · Lifeforce Series A

Scottie UpshallCo-invested · Lifeforce Series A

Scottie UpshallCo-invested · Lifeforce Series A

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Peter Diamandis's Investments

5 investments since 2015

5 operating

Investments view

Group by

2023

1

Lifeforce
Series A · May 2023$12M
Series A · May 2023

2018

1

Good Money
Series A · December 2018$30M
Series A · December 2018

2017

1

Mirror AI
Seed · December 2017$3.5M
Seed · December 2017

2016

1

Planetary Power
Series A · June 2016$3.4M
Series A · June 2016

2015

1

Experfy
Seed · June 2015$1.5M
Seed · June 2015

Investment FirmMountain View, CA, US

Co-Founder

Xprize

Non-ProfitCulver City, CA, US

Board Member· Board

Founder

Bold Capital Partners

Investment FirmSanta Monica, CA, US

Founder

Singularity University Ventures

Investment FirmMountain View, CA, US

Co-Founder

Vaxxinity

Public$9.3MDallas, TX, US

Board Member· Board

Co-Founder

Celularity

Public$400MFlorham Park, NJ, US

Board Member· Board

Fountain Therapeutics

Series A$26MStanford, CA, US

Board Member· Board

Fountain Life

Series B$17.1MNaples, FL, US

Co-Founder

Human Longevity

Series C$340.5MSan Diego, CA, US

Board Member· Board

Co-Founder

Troy CarterCo-invested · Good Money Series A

Justin RosensteinCo-invested · Good Money Series A

Mitch KaporCo-invested · Good Money Series A

Blake MycoskieCo-invested · Good Money Series A

Ken HoweryCo-invested · Good Money Series A

People Similar to Peter Diamandis

Ray KurzweilCo-Founder · Singularity University

Ronald WilheimCo-Founder · Longevity Venture Partners

Dean SawyerBoard Member · Singularity University

Kathryn MyronukBoard Member · Singularity University

Andrew HesselBoard Member · Singularity University

Ramez NaamBoard Member · Singularity University

Leadership at Singularity University

Pascal FinetteBoard Member

Eric RiesBoard Member

Darlene DammBoard Member

Ketan PatelBoard Member

Nicholas HaanBoard Member

David S. RoseBoard Member

Similar to Singularity University

Singularity University VenturesMountain View, CA, USest. 2009Singularity University VenturesMountain View, CA, US · est. 2009

Singularity University Ventures: A leading global impact investment platform, bridging startups with investors to solve global challenges.

Investment Firm375

Leadership at Xprize

Sony MordechaiBoard Member

Daniel KraftBoard Member

Anousheh AnsariBoard Member

Naveen JainBoard Member

Richard GarriottBoard Member

Jack BaderBoard Member

Similar to Xprize

The Thiel FoundationSan Francisco, CA, USGrants, Philanthropyest. 2006The Thiel FoundationSan Francisco, CA, US · est. 2006

Thiel Foundation: Empowering individuals through grants, championing human rights, and encouraging innovative ideas.

Recent news

Omeat emerges from stealth with beefy tech approach to cultivated meat growth mediaTechCrunch · 2023

Similar to Bold Capital Partners

BoldCapNew York City, NY, USest. 2016BoldCapNew York City, NY, US · est. 2016

Investing in tech and healthcare industries in the US.

Investment Firm4

Boldstart VenturesNew York City, NY, USest. 2010Boldstart VenturesNew York City, NY, US · est. 2010

Boldstart: A venture capital firm, collaborating with tech founders from inception, turning bold ideas into iconic companies.

Investment Firm25

Partners ResoluteNew York City, NY, USPartners ResoluteNew York City, NY, US

Early-stage venture capital firm specializing in alternative and resolute fundraising.

Investment Firm2

Bold Brain VenturesPittsburgh, PA, USest. 2018Bold Brain VenturesPittsburgh, PA, US · est. 2018

Bold Brain Ventures: An AI-focused investment fund specializing in radiology.

Investment Firm3

Leadership at Singularity University Ventures

Ray KurzweilCo-Founder

Monique GiggyCo-Founder

Similar to Singularity University Ventures

Singularity CapitalTucson, AZ, USest. 2019Singularity CapitalTucson, AZ, US · est. 2019

Singularity Capital: A tech-focused investment firm partnering with innovative companies for strategic problem-solving.

Investment Firm7.5k

Singularity UniversityMountain View, CA, USest. 2008Singularity UniversityMountain View, CA, US · est. 2008

Singularity Group: An American firm offering executive education, business incubation, and consultancy services.

Investment Firm600

Fifty YearsSan Francisco, CA, USest. 2015Fifty YearsSan Francisco, CA, US · est. 2015

Fifty Years: A San Francisco-based VC firm, funding tech solutions for global issues, targeting sustainable profitability.

Investment Firm27

Citi VenturesSan Francisco, CA, USest. 2008Citi VenturesSan Francisco, CA, US · est. 2008

Citi Ventures: A global investment firm innovating and investing in ideas for a tech-forward world.

Investment Firm76

Leadership at Vaxxinity

George Ronald HornigBoard Member

Lou ReeseBoard Member

Mei Mei HuCo-Founder

Mei mei tongCEO

Similar to Vaxxinity

VaccinexRochester, NY, USAntibodies, Vaccinesest. 1997VaccinexRochester, NY, US · est. 1997

US-based Vaccinex, Inc. develops therapeutic antibodies and vaccines for cancer, neurodegenerative diseases, and autoimmune disorders.

Public · $75.5M38

Leadership at Celularity

Jodi GurneyCo-Founder

Carlos RamirezCo-Founder

Robin SmithBoard Member

Steven FrenchCo-Founder

Marc MazurBoard Member

Dean KehlerBoard Member

Similar to Celularity

Platelet BioGenesisWatertown, MA, USCell Therapyest. 2014Platelet BioGenesisWatertown, MA, US · est. 2014

US-based PlateletBio pioneers in allogeneic cell therapy, innovating superior solutions for unmet medical challenges.

Series B · $132.1M39

Leadership at Fountain Therapeutics

William GreeneCEO

Thomas RandoBoard Member

Joseph RodgersCo-Founder

Similar to Fountain Therapeutics

Retro BiosciencesSan Francisco, CA, USTherapeuticsest. 2021Retro BiosciencesSan Francisco, CA, US · est. 2021

Retro Biosciences, an American medical firm, pioneers in cellular reprogramming and plasma-inspired therapeutics.

Deciduous TherapeuticsSan Francisco, CA, USTherapeuticsest. 2018Deciduous TherapeuticsSan Francisco, CA, US · est. 2018

Deciduous Therapeutics: Innovating immune-modulatory therapies to remove senescent cells, improving health-span and treating age-related diseases.

Seed · $16.5M37

Tranquis TherapeuticsSan Mateo, CA, USBiotech, Therapeuticsest. 2016Tranquis TherapeuticsSan Mateo, CA, US · est. 2016

Tranquis Therapeutics: Innovating medicines for neurodegenerative and aging-related diseases.

Series A · $30M35

Fountain LifeNaples, FL, USDiagnostics, HealthTechest. 2019Fountain LifeNaples, FL, US · est. 2019

Fountain Life: Integrated health tech provider for predictive, personalized, data-driven care.

Series B · $17.1M125

Leadership at Fountain Life

Robert HaririCo-Founder

Todd WanekCo-Founder

Tony RobbinsCo-Founder

William KappCEO

B.K. ModiCo-Founder

Similar to Fountain Life

HumanityBoston, MA, USHealthcareest. 2019HumanityBoston, MA, US · est. 2019

Humanity: A healthcare company dedicated to extending human healthspan.

Leadership at Human Longevity

Richard ScheuermannBoard Member

Robert HaririBoard Member

Max FoxBoard Member

Bryan JohnsonBoard Member

J. Craig VenterBoard Member

Similar to Human Longevity

Genome InsightSan Diego, CA, USGenome Sequencingest. 2020Genome InsightSan Diego, CA, US · est. 2020

Genome Insight: Expert in whole genome sequence analysis and interpretation.

Series B · $52.7M57

Singularity CapitalTucson, AZ, USest. 2019Singularity CapitalTucson, AZ, US · est. 2019

Singularity Capital: A tech-focused investment firm partnering with innovative companies for strategic problem-solving.

Investment Firm7.5k

Singularity InvestmentsLagos, NGest. 2016Singularity InvestmentsLagos, NG · est. 2016

Singularity Investments: Diverse portfolio management with scalable business models in Africa & North America.

Investment Firm7

Founder.orgSan Francisco, CA, USest. 2012Founder.orgSan Francisco, CA, US · est. 2012

San Francisco-based firm fostering student entrepreneurs through investment and company building.

Investment Firm20

Schmidt FuturesNew York City, NY, USGrants, Researchest. 2017

Schmidt FuturesNew York City, NY, US · est. 2017

Schmidt Futures: A philanthropic initiative leveraging emerging science and technology for societal betterment.

Nonprofit425

The Earthshot PrizeLondon, Greater London, GBEnvironmental Solutionsest. 2020The Earthshot PrizeLondon, Greater London, GB · est. 2020

Earthshot Prize: A global initiative incentivizing change to repair our planet in a decade.

Milken-Penn GSE Education Business Plan CompetitionPhiladelphia, PA, USest. 2010Milken-Penn GSE Education Business Plan CompetitionPhiladelphia, PA, US · est. 2010

Philadelphia-based educational organization, Milken-Penn GSE EBPC, fosters innovative solutions for equitable global education.

Versatope TherapeuticsLowell, MA, USBiopharmaceuticalsest. 2017

Versatope TherapeuticsLowell, MA, US · est. 2017

Versatope Therapeutics: Innovating immunity-focused drugs using synthetic biology for biopharmaceutical applications.

Angel · $18.4M17

X-Vax TechnologyJupiter, FL, USVaccinesest. 2015X-Vax TechnologyJupiter, FL, US · est. 2015

X-Vax: A biotech firm specializing in developing vaccines for mucosal infection pathogens.

Series A · $56M39

CentivaxSouth San Francisco, CA, USTherapeutics, Vaccinesest. 2020CentivaxSouth San Francisco, CA, US · est. 2020

Centivax: A healthcare agency offering biotech, pharma, medical device manufacturing & therapeutics.

Seed · $14.2M20

LongeveronMiami, FL, USCellular Therapiesest. 2014

LongeveronMiami, FL, US · est. 2014

Longeveron Inc., a clinical-stage biotech firm, develops cellular therapies for aging-related and life-threatening conditions globally.

Public · $15.4M11

Cell BioEnginesNew York City, NY, USCell Therapiesest. 2022Cell BioEnginesNew York City, NY, US · est. 2022

Cell BioEngines, Inc.: A clinical-stage biotech firm innovating cancer cures with scalable cell therapies.

Pre-Seed · $625k6

HebeCellNatick, MA, USCell Therapiesest. 2016HebeCellNatick, MA, US · est. 2016

MA-based HebeCell pioneers in immuno-oncology and regenerative medicine through cell-based therapeutics.

Series A · $63M24

LifeNomeNew York City, NY, USWellness Solutionsest. 2016

LifeNomeNew York City, NY, US · est. 2016

LifeNome leverages AI & Genomics for B2B personalized wellness and preventive care solutions.

Seed · $2.1M24

LifeQAlpharetta, GA, USHealth Monitoringest. 2014LifeQAlpharetta, GA, US · est. 2014

LifeQ: A health and wellbeing company dedicated to fostering optimal health for all.

Series A · $47M53

Fountain TherapeuticsStanford, CA, USTreatmentsest. 2018Fountain TherapeuticsStanford, CA, US · est. 2018

Fountain Therapeutics develops treatments for aging-associated diseases.

Series A · $26M37

HelixSan Mateo, CA, USGenomic Testingest. 2015

HelixSan Mateo, CA, US · est. 2015

Helix, a leading population genomics startup, advances genomic research and integrates it into clinical care.

Series C · $403M150

Lightspeed GenomicsSanta Clara, CA, USDiagnostics, DNA Sequencingest. 2006Lightspeed GenomicsSanta Clara, CA, US · est. 2006

LightSpeed Genomics: Pioneering human genome sequencing and life science diagnostics.

Series A · $5.1M30

Generation LabSan Francisco, CA, USHealth SoftwareGeneration LabSan Francisco, CA, US

San Francisco-based Generation Lab develops software for biological age and disease risk assessment, promoting healthier lives.